Skip to content

SOLENO THERAPEUTICS INC

CIK 0001484565

← back to feed
Revenue (TTM)
$1.45M
+138.8% YoY Q1 Apr 2026
Net Income (TTM)
$8.91M
+111.9% YoY Q1 Apr 2026
EPS Diluted (TTM)
$0.02
+108.9% YoY Q1 Apr 2026
Gross Margin
-7.2%
Q1 Apr 2026
Operating Margin
76.9%
Q1 Apr 2026
Net Margin
614.1%
Q1 Apr 2026
Free Cash Flow (TTM)
−$26.08M
Q1 Apr 2026
Cash
$133.03M
Q1 Apr 2026
Total Debt
$49.87M
Q1 Apr 2026
Shares Outstanding
52.12M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings